![John Eric Milad](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Eric Milad
Directeur/Membre du Conseil chez
NORTHERN VENTURE TRUST PLC
Profil
John Eric Milad is the founder of Quanta Dialysis Technologies Ltd. since 2008, holding the title of Chief Executive Officer & Director.
Current jobs include Chief Executive Officer at ERS Genomics Ltd. since 2024, Independent Non-Executive Director at Northern Venture Trust Plc since 2024, Director at Kidney Research UK Ltd., and Director at Otivio AS.
Former jobs include Director at Symetis SA, Director at BONESUPPORT HOLDING AB, Director at Cellnovo Group SA, Special Advisor at Atlas Venture LLP, CFO & Head-Business Development at Horizon Therapeutics Switzerland GmbH, and Investment Director at Stage Capital Ventures in 2013.
Education includes an undergraduate degree from The University of Chicago.
Postes actifs de John Eric Milad
| Sociétés | Poste | Début |
|---|---|---|
| NORTHERN VENTURE TRUST PLC | Directeur/Membre du Conseil | 21/08/2024 |
ERS Genomics Ltd.
 ERS Genomics Ltd. BiotechnologyHealth Technology Develops biotechnology products | Directeur Général | 13/05/2024 |
Kidney Research UK Ltd.
 Kidney Research UK Ltd. Miscellaneous Commercial ServicesCommercial Services Operates organization for conducting research in kidney diseases | Directeur/Membre du Conseil | - |
Otivio AS
 Otivio AS Medical SpecialtiesHealth Technology Manufactures non invasive medical devices | Directeur/Membre du Conseil | - |
Anciens postes connus de John Eric Milad
| Sociétés | Poste | Fin |
|---|---|---|
Stage Capital Ventures
 Stage Capital Ventures Investment ManagersFinance Stage Capital Ventures focuses on investments in early-stage, high growth technology-centric companies across Europe primarily in the medical technologies and related sectors, including those that design, manufacture and supply diagnostic equipment, therapeutic devices and other health-related products and software. | Private Equity Investor | 01/12/2013 |
Atlas Venture LLP
 Atlas Venture LLP Investment ManagersFinance Atlas Venture is a leading international venture capital investment manager specialized in sectors including life sciences, communications and information technology and investing in Europe and the US. The firm targets early-stage, science-based businesses and leads the first financing round, generally acquiring a significant minority stake which grants them board representation. They subsequently help recruiting a management team to carry the emerging business forward, typically towards international expansion. Atlas Venture also invests in later-stage operations such as corporate spin-offs and down financing. Investment criteria include leadership potential in a global high-growth market, market momentum and a proprietary disruptive technology or business model. In the technology industry, Atlas Venture focuses on components, systems, software and services. The group has invested in data warehousing, storage systems for digital media, core chips for mobile phones and MEMS-based displays for mobile devices. Their biotechnology investments focus on drug discovery. They have invested in blood-thinning agents, small interfering RNA, emerging cancer drugs and anti-infectives. Atlas Venture sources deals though a combination of top-down global market analysis and bottom-up local connections in their industries of choice, including contacts in the academic world. Their exit strategies are international and include M&A transactions and IPOs on a variety of exchanges. | Corporate Officer/Principal | - |
Quanta Dialysis Technologies Ltd.
 Quanta Dialysis Technologies Ltd. Medical SpecialtiesHealth Technology Develops hemodialysis systems | Fondateur | - |
| CELLNOVO | Directeur/Membre du Conseil | - |
| SYMETIS SA | Directeur/Membre du Conseil | - |
Formation de John Eric Milad
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
6
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Northern Venture Trust Plc
 Northern Venture Trust Plc Investment ManagersFinance Functions as a private equity fund | Finance |
Atlas Venture LLP
Atlas Venture LLP Investment ManagersFinance Atlas Venture is a leading international venture capital investment manager specialized in sectors including life sciences, communications and information technology and investing in Europe and the US. The firm targets early-stage, science-based businesses and leads the first financing round, generally acquiring a significant minority stake which grants them board representation. They subsequently help recruiting a management team to carry the emerging business forward, typically towards international expansion. Atlas Venture also invests in later-stage operations such as corporate spin-offs and down financing. Investment criteria include leadership potential in a global high-growth market, market momentum and a proprietary disruptive technology or business model. In the technology industry, Atlas Venture focuses on components, systems, software and services. The group has invested in data warehousing, storage systems for digital media, core chips for mobile phones and MEMS-based displays for mobile devices. Their biotechnology investments focus on drug discovery. They have invested in blood-thinning agents, small interfering RNA, emerging cancer drugs and anti-infectives. Atlas Venture sources deals though a combination of top-down global market analysis and bottom-up local connections in their industries of choice, including contacts in the academic world. Their exit strategies are international and include M&A transactions and IPOs on a variety of exchanges. | Finance |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Horizon Therapeutics Switzerland GmbH
 Horizon Therapeutics Switzerland GmbH Pharmaceuticals: MajorHealth Technology Discovers and develops medicines for the treatment of chronic inflammatory diseases | Health Technology |
Symetis SA
 Symetis SA BiotechnologyHealth Technology Develops products for pediatric cardio-vascular applications | Health Technology |
Stage Capital Ventures
Stage Capital Ventures Investment ManagersFinance Stage Capital Ventures focuses on investments in early-stage, high growth technology-centric companies across Europe primarily in the medical technologies and related sectors, including those that design, manufacture and supply diagnostic equipment, therapeutic devices and other health-related products and software. | Finance |
BONESUPPORT HOLDING AB
 BONESUPPORT HOLDING AB Medical SpecialtiesHealth Technology Develops and sells injectable, synthetic ceramic bone substitutes and injection accessories | Health Technology |
Cellnovo Group SA
 Cellnovo Group SA Medical SpecialtiesHealth Technology Manufactures medical device that manages diabetic control | Health Technology |
Quanta Dialysis Technologies Ltd.
Quanta Dialysis Technologies Ltd. Medical SpecialtiesHealth Technology Develops hemodialysis systems | Health Technology |
Kidney Research UK Ltd.
Kidney Research UK Ltd. Miscellaneous Commercial ServicesCommercial Services Operates organization for conducting research in kidney diseases | Commercial Services |
Otivio AS
Otivio AS Medical SpecialtiesHealth Technology Manufactures non invasive medical devices | Health Technology |
ERS Genomics Ltd.
ERS Genomics Ltd. BiotechnologyHealth Technology Develops biotechnology products | Health Technology |
